Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 216 entries
View as:

Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00308685 Org: User:
Start: 06/10/06 End: 12/04/06 Due: 12/04/07

Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017

Phase: N/A Priority: Normal
NCT ID: NCT02315131 Org: User:
Start: 03/31/15 End: 08/31/15 Due: 08/31/16

Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00232999 Org: User:
Start: 10/31/05 End: 01/31/06 Due: 01/31/07

A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT05693935 Org: User:
Start: 01/24/23 End: 01/27/25 Due: 01/27/26

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Phase: N/A Priority: Normal
NCT ID: NCT00240032 Org: User:
Start: 10/31/04 End: 07/31/06 Due: 07/31/07

A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee

Phase: N/A Priority: Normal
NCT ID: NCT02068599 Org: User:
Start: 04/14/14 End: 05/04/15 Due: 05/04/16

A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Patients 6 to 17 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT04464707 Org: User:
Start: 07/30/20 End: 11/29/24 Due: 11/29/25

A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01287039 Org: User:
Start: 04/30/11 End: 03/31/14 Due: 03/31/15

Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00085774 Org: User:
Start: 06/30/04 End: 09/30/04 Due: 09/30/05

Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03452943 Org: User:
Start: 02/05/18 End: 11/12/19 Due: 11/12/20

Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT00837265 Org: User:
Start: 08/21/08 End: 06/26/09 Due: 06/26/10

A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00203086 Org: User:
Start: 10/31/05 End: 12/31/09 Due: 12/31/10

A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02040779 Org: User:
Start: 12/26/13 End: 12/24/14 Due: 12/24/15

Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS

Phase: N/A Priority: Normal
NCT ID: NCT00202995 Org: User:
Start: 07/31/04 End: 10/31/07 Due: 10/31/08

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Phase: N/A Priority: Normal
NCT ID: NCT00062504 Org: User:
Start: 07/31/03 End: 04/30/06 Due: 04/30/07

Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)

Phase: N/A Priority: Normal
NCT ID: NCT02410356 Org: User:
Start: 04/30/15 End: 04/30/16 Due: 04/30/17

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Phase: N/A Priority: Normal
NCT ID: NCT02945046 Org: User:
Start: 01/19/17 End: 05/13/19 Due: 05/13/20

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Phase: N/A Priority: Normal
NCT ID: NCT01218009 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06319170 Org: User:
Start: 03/28/24 End: 01/15/25 Due: 01/15/26

Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01940601 Org: User:
Start: 09/30/14 End: 12/31/15 Due: 12/31/16

Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00203164 Org: User:
Start: 05/31/02 End: 09/30/06 Due: 09/30/07

Albuterol HFA MDI in Pediatric Participants With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT00577655 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

Study to Characterize the Pharmacokinetics and Safety of TV-45070 Ointment in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02215941 Org: User:
Start: 08/31/14 End: 02/28/15 Due: 02/28/16

A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00724048 Org: User:
Start: 10/24/08 End: 07/26/10 Due: 07/26/11

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02513160 Org: User:
Start: 09/30/15 End: 03/31/16 Due: 03/31/17